A prospective cohort study of periodontal disease measures and cardiovascular disease markers in HIV-infected adults

AIDS Research and Human Retroviruses

Volumn 27, Issue 11, 2011, Pages 1157-1166

  Vernon, Lance T ^a   Babineau, Denise C ^a   Demko, Catherine A ^a   Lederman, Michael M ^b   Wang, Xuelei ^a   Toossi, Zahra ^b   Weinberg, Aaron ^a   Rodriguez, Benigno ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTERIAL WALL THICKNESS; ARTERY BLOOD FLOW; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CLINICAL ARTICLE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FLOW MEDIATED DILATION; FOLLOW UP; GINGIVA DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; VASODILATATION;

ADULT; BACTEROIDACEAE INFECTIONS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS; PROSPECTIVE STUDIES; TUNICA INTIMA; TUNICA MEDIA;

EID: 80655128341     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0320     Document Type: Article

References (59)

1. Friis-Moller N, Sabin CA, Weber R, et al.: Combination an-tiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003;349(21):1993- 2003.
2. Triant VA, Lee H, Hadigan C, and Grinspoon SK: Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007;92(7):2506-2512. (Pubitemid 47037350)
3. Bozzette SA, Ake CF, Tam HK, Chang SW, and Louis TA: Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003;348(8):702-710. (Pubitemid 36237039)
4. Mangili A, Jacobson DL, Gerrior J, Polak JF, Gorbach SL, and Wanke CA: Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV. Clin Infect Dis 2007; 44(10):1368-1374. (Pubitemid 46717301)
5. Mercie P, Thiebaut R, Lavignolle V, et al.: Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid in-tima-media thickness measurement. Ann Med 2002;34(1):55-63. (Pubitemid 34454422)
6. Nolan D, Watts GF, Herrmann SE, French MA, John M, and Mallal S: Endothelial function in HIV-infected patients receiving protease inhibitor therapy: Does immune competence affect cardiovascular risk? QJM 2003;96(11):825-832. (Pubitemid 37369296)
7. Stein JH, Klein MA, Bellehumeur JL, et al.: Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 2001;104(3):257-262. (Pubitemid 32666944)
8. Torriani FJ, Komarow L, Parker RA, et al.: Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol 2008;52(7): 569-576.
9. van Wijk JP, de Koning EJ, Cabezas MC, et al.: Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients. J Am Coll Cardiol 2006;47(6):1117-1123.
10. Lekakis J, Tsiodras S, Ikonomidis I, et al.: HIV-positive patients treated with protease inhibitors have vascular changes resembling those observed in atherosclerotic cardiovascular disease. Clin Sci (Lond) 2008;115(6):189-196.
11. Hsue PY, Hunt PW, Sinclair E, et al.: Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS 2006;20(18):2275-2283. (Pubitemid 44789529)
12. Hsue PY, Hunt PW, Schnell A, et al.: Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS 2009;23(9):1059-1067.
13. Currier JS, Kendall MA, Zackin R, et al.: Carotid artery in-tima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS 2005;19(9):927-933. (Pubitemid 40834935)
14. Hsue PY, Lo JC, Franklin A, et al.: Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 2004;109(13):1603-1608. (Pubitemid 38451715)
15. Currier JS, Kendall MA, Henry WK, et al.: Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS 2007;21(9):1137-1145. (Pubitemid 46763284)
16. Mercie P, Thiebaut R, Aurillac-Lavignolle V, et al.: Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients. HIV Med 2005;6(6):380-387. (Pubitemid 41741590)
17. Odueyungbo A, Smieja M, Thabane L, et al.: Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: A prospective cohort study. AIDS Res Ther 2009;6:11.
18. Mujawar Z, Rose H, Morrow MP, et al.: Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol 2006;4(11):e365.
19. Bussolino F, Mitola S, Serini G, Barillari G, and Ensoli B: Interactions between endothelial cells and HIV-1. Int J Bio-chem Cell Biol 2001;33(4):371-390. (Pubitemid 32324005)
20. Eugenin EA, Morgello S, Klotman ME, et al.: Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: Implications for the path-ogenesis of HIV-mediated vascular disease. Am J Pathol 2008;172(4):1100-1111. (Pubitemid 351520006)
21. Tebas P, Henry WK, Matining R, et al.: Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: Implications for cardiovascular risk. PLoS One 2008;3(4):e2021.
22. Funderburg NT, Mayne E, Sieg SF, et al.: Increased tissue factor expression on circulating monocytes in chronic HIV infection: Relationship to in vivo coagulation and immune activation. Blood 2010;115(2):161-167.
23. van Vonderen MG, Smulders YM, Stehouwer CD, et al.: Carotid intima-media thickness and arterial stiffness in HIV-infected patients: The role of HIV, antiretroviral therapy, and lipodystrophy. J Acquir Immune Defic Syndr 2009;50(2): 153-161.
24. Beck JD and Offenbacher S: Systemic effects of periodontitis: Epidemiology of periodontal disease and cardiovascular disease. J Periodontol 2005;76(11 Suppl):2089-2100. (Pubitemid 41748958)
25. Genco R, Offenbacher S, and Beck J: Periodontal disease and cardiovascular disease: epidemiology and possible mechanisms. J Am Dent Assoc 2002;133(Suppl):14S-22S.
26. Li L, Messas E, Batista EL, Jr., Levine RA, and Amar S: Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002;105(7):861-867. (Pubitemid 34174928)
27. Lalla E, Lamster IB, Hofmann MA, et al.: Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2003;23(8):1405-1411. (Pubitemid 36994529)
28. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, and Genco RJ: Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000;71(10):1554-1560.
29. Tonetti MS, D'Aiuto F, Nibali L, et al.: Treatment of peri-odontitis and endothelial function. N Engl J Med 2007; 356(9):911-920.
30. Piconi S, Trabattoni D, Luraghi C, et al.: Treatment of peri-odontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness. FASEB J 2009;23(4):1196-1204.
31. Vernon LT, Demko CA, Whalen CC, et al.: Characterizing traditionally defined periodontal disease in HIV+ adults. Community Dent Oral Epidemiol 2009;37(5):427-437.
32. Tong DRB: Antibiotic prophylaxis in dentistry: A review and practice recommendations. J Am Dent Assoc 2000;131: 366-374.
33. Advisory statement: Antibiotic prophylaxis for dental patients with total joint replacements. American Dental Association; American Academy of Orthopaedic Surgeons. J Am Dent Assoc 1997, 128(7). 1004-1008.
34. Corretti MC, Anderson TJ, Benjamin EJ, et al.: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39(2):257-265. (Pubitemid 34084631)
35. Tien PC, Benson C, Zolopa AR, Sidney S, Osmond D, and Grunfeld C: The study of fat redistribution and metabolic change in HIV infection (FRAM): Methods, design, and sample characteristics. Am J Epidemiol 2006;163(9):860-869.
36. O'Leary DH, Polak JF, Wolfson SK, Jr., et al.: Use of sonog-raphy to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 1991;22(9):1155-1163.
37. Socransky SS, Haffajee AD, Cugini MA, Smith C, and Kent RL Jr: Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25(2):134-144. (Pubitemid 128705944)
38. Morillo JM, Lau L, Sanz M, Herrera D, Martin C, and Silva A: Quantitative real-time polymerase chain reaction based on single copy gene sequence for detection of periodontal pathogens. J Clin Periodontol 2004;31(12):1054-1060. (Pubitemid 39643701)
39. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Trea-cher DF, and Turner RC: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28(7):412-419. (Pubitemid 15018832)
40. McComsey GA, O'Riordan M, Hazen SL, et al.: Increased carotid intima media thickness and cardiac biomarkers in HIV infected children. AIDS 2007;21(8):921-927. (Pubitemid 46684323)
41. Lorenz MW, Markus HS, Bots ML, Rosvall M, and Sitzer M: Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation 2007;115(4):459-467. (Pubitemid 46184197)
42. Gibson FC, 3rd, Hong C, Chou HH, et al.: Innate immune recognition of invasive bacteria accelerates atherosclerosis in apo-lipoprotein E-deficient mice. Circulation 2004;109(22):2801-2806.
43. Miyamoto T, Yumoto H, Takahashi Y, Davey M, Gibson FC, 3rd, and Genco CA: Pathogen-accelerated atherosclerosis occurs early after exposure and can be prevented via immunization. Infect Immun 2006;74(2):1376-1380. (Pubitemid 43185578)
44. Hayashi C, Gudino CV, Gibson FC, 3rd, and Genco CA: Review: Pathogen-induced inflammation at sites distant from oral infection: Bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol Oral Microbiol 2010;25(5):305-316.
45. Zeituni AE, Jotwani R, Carrion J, and Cutler CW: Targeting of DC-SIGN on human dendritic cells by minor fimbriated Porphyromonas gingivalis strains elicits a distinct effector T cell response. J Immunol 2009;183(9):5694-5704.
46. Pollreisz A, Hudson BI, Chang JS, et al.: Receptor for advanced glycation endproducts mediates pro-atherogenic responses to periodontal infection in vascular endothelial cells. Atherosclerosis 2010;212(2):451-456.
47. Humphrey LL, Fu R, Buckley DI, Freeman M, and Helfand M: Periodontal disease and coronary heart disease incidence: A systematic review and meta-analysis. J Gen Intern Med 2008;23(12):2079-2086.
48. Offenbacher S, Barros SP, Singer RE, Moss K, Williams RC, and Beck JD: Periodontal disease at the biofilm-gingival interface. J Periodontol 2007;78(10):1911-1925.
49. Beck JD, Eke P, Lin D, et al.: Associations between IgG antibody to oral organisms and carotid intima-medial thickness in community-dwelling adults. Atherosclerosis 2005; 183(2):342-348. (Pubitemid 41579287)
50. Desvarieux M, Demmer RT, Rundek T, et al.: Periodontal microbiota and carotid intima-media thickness: The Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 2005;111(5):576-582. (Pubitemid 40216484)
51. Desvarieux M, Demmer RT, Jacobs DR Jr, et al.: Periodontal bacteria and hypertension: The oral infections and vascular disease epidemiology study (INVEST). J Hypertens 2010; 28(7):1413-1421.
52. Demmer RT, Papapanou PN, Jacobs DR Jr, and Desvarieux M: Evaluating clinical periodontal measures as surrogates for bacterial exposure: The Oral Infections and Vascular Disease Epidemiology Study (INVEST). BMC Med Res Methodol 2010;10:2.
53. Demmer RT, Papapanou PN, Jacobs DR Jr, and Desvarieux M: Bleeding on probing differentially relates to bacterial profiles: The Oral Infections and Vascular Disease Epidemiology Study. J Clin Periodontol 2008;35(6):479-486.
54. Beck JD and Offenbacher S: Relationships among clinical measures of periodontal disease and their associations with systemic markers. Ann Periodontol 2002;7(1):79-89.
55. Bots ML, Evans GW, Riley WA, and Grobbee DE: Carotid intima-media thickness measurements in intervention studies: Design options, progression rates, and sample size considerations: A point of view. Stroke 2003;34(12):2985-2994. (Pubitemid 37517782)
56. Beck JD, Eke P, Heiss G, et al.: Periodontal disease and coronary heart disease: A reappraisal of the exposure. Circulation 2005;112(1):19-24. (Pubitemid 40962564)
57. Sackoff JE, Hanna DB, Pfeiffer MR, and Torian LV: Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 2006;145(6):397-406. (Pubitemid 46768570)
58. Crum NF, Riffenburgh RH, Wegner S, et al.: Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 2006;41(2):194-200.
59. Hall HI, Song R, Rhodes P, et al.: Estimation of HIV incidence in the United States. JAMA 2008;300(5): 520-529